VA Senate Leader Indicted, D.C. Medical Sales Top $10.2M: Weekly Roundup

It was a busy stretch for cannabis policy and business news along the East Coast, with developments in Virginia, Washington, D.C., and Maryland all landing at once.

The biggest headline came out of Virginia, where a federal indictment has targeted the leader of the state Senate. The charges are tied to an alleged illegal cannabis operation, which puts the Commonwealth's still-unsettled cannabis landscape under a harsh spotlight. As with any indictment, the charges are allegations, and the case has yet to be tested in court.

In D.C., the numbers were more encouraging. Medical cannabis revenue reached $10.2 million for September, a figure that signals the District's regulated market is holding steady and, in some segments, growing. The detail behind that total shows where the activity is coming from, with the supply side of the market doing a good share of the lifting.

D.C. regulators were also busy on the enforcement side. Authorities moved against a cannabis vendor operating at the H Street Festival, a reminder that the District keeps a close eye on who is allowed to sell and where. For consumers, the takeaway is simple: unlicensed pop-up sales at public events carry real regulatory risk, and the products involved haven't gone through the testing and oversight that licensed shops must follow.

On the product front, EasyDay introduced an inhaler, adding another option to the growing list of alternative consumption formats for people who want something different from a joint or a vape pen. Details on the launch were limited in the original rundown.

Finally, Metrc scheduled a webinar for Maryland, aimed at operators who work with the state's tracking system. Compliance software remains a core part of how cannabis businesses stay in good standing, and sessions like this help the industry keep up with changing requirements.